Get the Stockscreener App
1.61
9.40%
0.12
Cue Biopharma Inc stock is traded at $1.61, with a volume of 554.83K.
It is up +9.40% in the last 24 hours and up +40.52% over the past month.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
See More
Previous Close:
$1.49
Open:
$1.48
24h Volume:
554.83K
Relative Volume:
0.90
Market Cap:
$91.51M
Revenue:
$3.82M
Net Income/Loss:
$-51.89M
P/E Ratio:
-1.2677
EPS:
-1.27
Net Cash Flow:
$-39.52M
1W Performance:
-3.55%
1M Performance:
+40.52%
6M Performance:
-23.47%
1Y Performance:
-33.47%
1-Day Range:
$1.323
$1.64
1-Week Range:
$1.323
$1.8986
52-Week Range:
$0.45
$3.2491
Cue Biopharma Inc Stock (CUE) Company Profile
Name
Cue Biopharma Inc
Sector
Industry
Phone
617-949-2680
Address
40 GUEST STREET, BOSTON, MA
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-26-23 | Resumed | Oppenheimer | Outperform |
| Nov-21-22 | Initiated | Piper Sandler | Overweight |
| Jan-13-22 | Initiated | H.C. Wainwright | Buy |
| Jan-03-22 | Initiated | Craig Hallum | Buy |
| Nov-24-20 | Initiated | Berenberg | Buy |
| Apr-09-20 | Initiated | Stifel | Buy |
| Jan-28-20 | Initiated | BTIG Research | Buy |
| Jan-22-20 | Initiated | JMP Securities | Mkt Outperform |
View All
Cue Biopharma Inc Stock (CUE) Latest News
Cue Biopharma, Inc. (NASDAQ:CUE) Short Interest Update - MarketBeat
Cue Biopharma authorizes more shares By Investing.com - Investing.com Australia
Cue Biopharma authorizes more shares - Investing.com India
There is no doubt that Cue Biopharma Inc (CUE) ticks all the boxes. - SETE News
Market Watch: Cue Biopharma Inc (CUE)’s Noteworthy Drop, Closing at 1.23 - The Dwinnex
Cue Biopharma (NASDAQ:CUE) adds US$31m to market cap in the past 7 days, though investors from three years ago are still down 89% - Yahoo Finance
Technical analysis of Cue Biopharma Inc (CUE) stock chart patterns - US Post News
Cue Biopharma stock rallies nearly 40% on upcoming presentations - MSN
Cue Biopharma amends loan agreement, easing cash requirements - Investing.com India
Cue Biopharma amends loan agreement, easing cash requirements By Investing.com - Investing.com UK
Cue Biopharma Announces Upcoming Scientific Presentations - GlobeNewswire
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting - StockTitan
Quarterly Snapshot: Quick and Current Ratios for Cue Biopharma Inc (CUE) - The Dwinnex
Biotech layoff tracker: 13 biotechs cut over 1,400 jobs - The Business Journals
Views of Wall Street’s Leading Experts on Cue Biopharma Inc - SETE News
What to expect from Cue Biopharma Inc’s (CUE) current quarter earnings? - US Post News
Cue Biopharma Inc (CUE) Stock: A Year of Highs and Lows - The InvestChronicle
Form 424B5 Cue Biopharma, Inc. - StreetInsider.com
SEC Form 424B5 filed by Cue Biopharma Inc. - Quantisnow
Wall Street SWOT: Cue Biopharma stock pivots to autoimmune focus amid restructuring - Investing.com India
Cue biopharma announces proposed public offering - MSN
Cue Biopharma prices $12M stock offering - MSN
Cue Biopharma Prices of $12.0 Million Public Offering - citybiz
Cue Biopharma Announces Pricing of $12.0 Million Public Offering - StockTitan
Cue Biopharma Announces Proposed Public Offering - The Bakersfield Californian
Cue Biopharma launches public stock offering By Investing.com - Investing.com Australia
Cue Biopharma launches public stock offering - Investing.com
Universal Music Group establishes new division in China’s Greater Bay Area, led by Gary Chan - Music Business Worldwide
Universal Music China Greater Bay Area launches to 'drive forward Chinese pop' - Music Week
UMG Muscles Into Hong Kong and Macau with ‘Universal Music China Greater Bay Area (UMCGBA)’ - Digital Music News
UNIVERSAL MUSIC GROUP LAUNCHES UNIVERSAL MUSIC CHINA GREATER BAY AREA - PR Newswire
Reason why UXIN stock surged today and could keep going - Journal Transcript
Cue Biopharma stock plunges to 52-week low of $0.53 By Investing.com - Investing.com Australia
Cue Biopharma stock plunges to 52-week low of $0.53 - Investing.com
Cue Biopharma names J&J vet Lucinda Warren as CBO - The Pharma Letter
Cue Biopharma names Lucinda Warren as new chief business officer - Investing.com
Cue Biopharma names Lucinda Warren as new chief business officer By Investing.com - Investing.com Canada
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer - GlobeNewswire
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer - GlobeNewswire Inc.
Cue Biopharma stock plunges to 52-week low at $0.58 amid market challenges - Investing.com
Cue Biopharma announces director Michael J. Fox's resignation - Investing.com
Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference - GlobeNewswire
Cue Biopharma Inc (CUE) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle
Cue Biopharma Inc Stock (CUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):